Regeneron Pharmaceuticals to expand HQ and labs

Will create 400 skilled jobs in Westchester County

Regeneron Pharmaceuticals is to expand its corporate headquarters and laboratories in New York State and create more than 400 skilled jobs.

The US biotech firm will add two new buildings with 300,000ft2 of laboratory and office space to its complex in Tarrytown, Westchester County. The company currently occupies approximately 590,000ft2 of space at the site and will take up a further 85,000ft2 there later this year.

Regeneron says the expansion will enable it to continue to accommodate the rapid growth it has experienced over the last six years — from 682 employees in 2007 to 2,000 today, including more than 1,300 employees in Tarrytown and nearly 600 at its industrial operations and product supply facility in Rensselaer, New York.

Construction of the new buildings is anticipated to begin towards the end of this year and to be completed in late 2015.

‘Our recently approved drugs and our robust development pipeline have transformed Regeneron into one of the largest and fastest-growing biopharmaceutical companies in the US,’ said Leonard Schleifer, President and Chief Executive of Regeneron.

‘Regeneron has been based in New York since we began 25 years ago, and we are grateful to Governor Cuomo and New York State for financial support that helps us to continue to expand and create jobs in New York.’

Last November, Cuomo revealed Regeneron’s plans to invest nearly US$70m to expand its manufacturing capacity in Rensselaer and create 300 new jobs.

With the Rensselaer and Tarrytown expansions, the company will create more than 700 new jobs in New York State and invest approximately $170m in capital expansion in New York over the next few years.

Companies